| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2012 | WO2012099449A3 Novel use of flavone-based compound |
| 12/06/2012 | WO2012099381A3 Preparation method of intermediate of sitagliptin |
| 12/06/2012 | WO2012091523A3 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof |
| 12/06/2012 | WO2012091425A3 Composition containing a 4-hydroxytamoxifen analog or the pharmaceutically acceptable salts thereof as an active ingredient for preventing or treating diseases associated with metabolic syndrome |
| 12/06/2012 | WO2012088182A3 2,4,5-triaminothiophenols and related compounds |
| 12/06/2012 | WO2012083408A8 Anti-malaria pharmaceutical compositions containing kaurenic diterpene derivatives |
| 12/06/2012 | WO2012083090A3 Methods and compounds for preparing 3alpha-oxygen substituted steroids |
| 12/06/2012 | WO2012079092A3 Testosterone undecanoate compositions |
| 12/06/2012 | WO2012078559A3 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same |
| 12/06/2012 | WO2012061662A9 Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors |
| 12/06/2012 | WO2012050370A3 Composition for preventing or treating rheumatoid arthritis containing a gamma secretase inhibitor as an active ingredient |
| 12/06/2012 | WO2012048285A8 Delivery of bisphosphonates by microinjection systems |
| 12/06/2012 | WO2012012891A8 Compounds, compositions and methods for treatment of arthritis |
| 12/06/2012 | WO2012012710A3 Radiation sensitization agents for prostate cancer |
| 12/06/2012 | WO2011144335A8 Stable ready to use injectable paracetamol formulation |
| 12/06/2012 | WO2011134084A8 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 12/06/2012 | WO2011127244A8 ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT |
| 12/06/2012 | US20120311728 Methods and pharmaceutical composition for the treatment of atherosclerosis |
| 12/06/2012 | US20120310211 Phentermine liquid dosage form |
| 12/06/2012 | US20120310187 Transparent transdermal nicotine delivery devices |
| 12/06/2012 | US20120310183 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| 12/06/2012 | US20120310144 Vision through photodynamic therapy of the eye |
| 12/06/2012 | US20120310141 Light delivery device and related compositions, methods and systems |
| 12/06/2012 | US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 12/06/2012 | US20120309848 Novel uses of nonenal |
| 12/06/2012 | US20120309847 Dosing regimens and methods for treating or preventing promyelocytic leukemia |
| 12/06/2012 | US20120309846 Dosing regimens and methods for treating or preventing myelodysplastic syndrome |
| 12/06/2012 | US20120309845 Dosing regimens and methods for treating or preventing acute myeloid leukemia |
| 12/06/2012 | US20120309843 Highly permeating terbinafine formulation |
| 12/06/2012 | US20120309842 Processes for the preparation of cinacalcet |
| 12/06/2012 | US20120309841 Method of Inhibiting Chronification of Pain |
| 12/06/2012 | US20120309840 Treatment of Pain Associated with Trigeminal Neuralgia |
| 12/06/2012 | US20120309839 Dosing regimes for trans-clomiphene |
| 12/06/2012 | US20120309838 Use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd) |
| 12/06/2012 | US20120309837 Bronchodilating Beta-Agonist Compositions and Methods |
| 12/06/2012 | US20120309836 Methods and compositions for administration of trpv1 agonists |
| 12/06/2012 | US20120309835 Methods, assays and compositions for treating retinol-related diseases |
| 12/06/2012 | US20120309834 Novel uses of adipic acid |
| 12/06/2012 | US20120309833 Novel bexarotene analogs |
| 12/06/2012 | US20120309832 Acetylcysteine Composition and Uses Thereof |
| 12/06/2012 | US20120309831 Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding |
| 12/06/2012 | US20120309829 Compositions including pyruvate for companion animals and methods of use thereof |
| 12/06/2012 | US20120309828 Compositions including pyruvate for companion animals and methods of use thereof |
| 12/06/2012 | US20120309827 Therapeutic compositions |
| 12/06/2012 | US20120309826 Stabilized pediatric suspension of carisbamate |
| 12/06/2012 | US20120309825 Nitrate Esters And Their Use For The Treatment Of Muscle And Muscle Related Diseases |
| 12/06/2012 | US20120309823 Percutaneous absorption preparations |
| 12/06/2012 | US20120309822 Treatment of infectious diseases |
| 12/06/2012 | US20120309821 Use of epigallocatechin-3-gallate for immune regulation |
| 12/06/2012 | US20120309820 Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids |
| 12/06/2012 | US20120309819 Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents |
| 12/06/2012 | US20120309818 Chronic inflammation and transplantation |
| 12/06/2012 | US20120309817 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 12/06/2012 | US20120309816 Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo |
| 12/06/2012 | US20120309815 Compositions and methods for topical delivery of oligonucleotides |
| 12/06/2012 | US20120309814 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 12/06/2012 | US20120309813 DELIVERY OF dsRNA TO ARTHROPODS |
| 12/06/2012 | US20120309812 Insecticidal compounds |
| 12/06/2012 | US20120309811 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators |
| 12/06/2012 | US20120309810 Treatment of atrial fibrillation |
| 12/06/2012 | US20120309809 Process and product |
| 12/06/2012 | US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences |
| 12/06/2012 | US20120309807 Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3) |
| 12/06/2012 | US20120309806 Process for the Sulfinylation of a Pyrazole Derivative |
| 12/06/2012 | US20120309805 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 12/06/2012 | US20120309804 Compositions and methods for treatment of glaucoma |
| 12/06/2012 | US20120309801 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 12/06/2012 | US20120309800 Metalloenzyme inhibitor compounds |
| 12/06/2012 | US20120309799 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 12/06/2012 | US20120309798 Tumour Treatment Agents and Method |
| 12/06/2012 | US20120309797 Pyridyl cyanoguanidine derivatives |
| 12/06/2012 | US20120309796 Benzocycloheptene acetic acids |
| 12/06/2012 | US20120309795 Heterocyclic inhibitors of necroptosis |
| 12/06/2012 | US20120309794 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 12/06/2012 | US20120309793 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 12/06/2012 | US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators |
| 12/06/2012 | US20120309791 Novel compound for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 12/06/2012 | US20120309790 Treatment of dermatological allergic conditions |
| 12/06/2012 | US20120309789 Compounds which have activity at M1 receptor and their uses in medicine |
| 12/06/2012 | US20120309788 Method for Treating Alzheimer's Disease Using Pharmacological Chaperones To Increase The Activity of Gangliosidases |
| 12/06/2012 | US20120309787 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| 12/06/2012 | US20120309786 3-amino-pyridine derivatives for the treatment of metabolic disorders |
| 12/06/2012 | US20120309785 Use of Cysteamine in Treating Parkinson's Disease |
| 12/06/2012 | US20120309784 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases |
| 12/06/2012 | US20120309783 Kinase inhibitors with improved cyp safety profile |
| 12/06/2012 | US20120309782 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS |
| 12/06/2012 | US20120309781 TETRAHYDRO-beta-CARBOLINE DERIVATIVES, SYNTHESIS AND USE THEREOF |
| 12/06/2012 | US20120309780 Micelle composition of polymer and passenger drug |
| 12/06/2012 | US20120309779 Methods and compositions comprising sequential administration of opioid receptor agonists |
| 12/06/2012 | US20120309778 Fused and Spirocycle Compounds and the Use Thereof |
| 12/06/2012 | US20120309777 Substituted 2-imidazolidones and analogs |
| 12/06/2012 | US20120309776 Pyrrolo[2,3-d]pyrimidine urea compounds as jak inhibitors |
| 12/06/2012 | US20120309775 4-methylpyridopyrimidinone compounds |
| 12/06/2012 | US20120309774 Selective antagonists of a2a adenosine receptors |
| 12/06/2012 | US20120309773 Heterocyclic compounds as janus kinase inhibitors |
| 12/06/2012 | US20120309772 Inhibitors of fatty acid uptake and methods of use |
| 12/06/2012 | US20120309771 Novel antifungal triazole derivatives |
| 12/06/2012 | US20120309770 Compounds for the Treatment of Hepatitis C |
| 12/06/2012 | US20120309769 N-benzylindole modulators of pparg |
| 12/06/2012 | US20120309768 Novel tubulin polymerisation inhibitors |